QCM
PCVX icon

Quantinno Capital Management’s Vaxcyte PCVX Stock Holding History

Quantinno Capital Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.25M Buy
55,880
+34,317
+159% +$1.86M ﹤0.01% 1577
2026
Q1 		$1.25M Buy
21,563
+7,062
+49% +$383K ﹤0.01% 1972
2025
Q4 		$669K Buy
14,501
+2,138
+17% +$95.6K ﹤0.01% 2126
2025
Q3 		$445K Sell
12,363
-1,565
-11% -$51.9K ﹤0.01% 2121
2025
Q2 		$453K Buy
+13,928
New +$457K ﹤0.01% 1718

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Quantinno Capital Management's PCVX Position: Q2 2026 in Review

Quantinno Capital Management increased its Vaxcyte (PCVX) stake by 159% in Q2 2026, buying an estimated $1.86M and bringing the position to 55,880 shares worth $3.25M. The position accounts for ﹤0.01% of the portfolio, ranked #1577.

Quantinno Capital Management first reported a position in PCVX in Q2 2025 and has held it in 5 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Quantinno Capital Management held 55,880 shares of Vaxcyte worth $3.25M as of Q2 2026.
  • Quantinno Capital Management bought 34,317 Vaxcyte shares in Q2 2026, an estimated $1.86M.
  • Vaxcyte made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1577 holding.
  • Quantinno Capital Management first reported a position in Vaxcyte in Q2 2025 and has held it in 5 quarters since.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.